{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:05:00Z","timestamp":1784037900657,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["RO1 CA142928"],"award-info":[{"award-number":["RO1 CA142928"]}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"crossref","award":["2011-15-012"],"award-info":[{"award-number":["2011-15-012"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH CORE","award":["P30 CA006927"],"award-info":[{"award-number":["P30 CA006927"]}]},{"name":"RSF","award":["14-24-00106"],"award-info":[{"award-number":["14-24-00106"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.biochi.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T13:20:05Z","timestamp":1483708805000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1"],"prefix":"10.1016","volume":"135","author":[{"given":"Galina","family":"Semenova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina S.","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey M.","family":"Deyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chernoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2017.01.001_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/1097-4547(20001215)62:6<755::AID-JNR1>3.0.CO;2-W","article-title":"Neurofibromatosis type 1. I. General overview","volume":"62","author":"Lakkis","year":"2000","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.biochi.2017.01.001_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.ejhg.5201676","article-title":"Neurofibromatosis 1","volume":"15","author":"Ferner","year":"2007","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"10.1016\/j.biochi.2017.01.001_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A\u00a0RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biochi.2017.01.001_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.biochi.2017.01.001_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.spen.2006.01.005","article-title":"Clinical manifestations and management of neurofibromatosis type 1","volume":"13","author":"Tonsgard","year":"2006","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.biochi.2017.01.001_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcdb.2016.02.007","article-title":"Neurofibromatosis type 1: fundamental insights into cell signalling and cancer","volume":"52","author":"Rad","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.biochi.2017.01.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2006.00639.x","article-title":"Neurofibromin: a general outlook","volume":"70","author":"Trovo-Marqui","year":"2006","journal-title":"Clin. Genet."},{"key":"10.1016\/j.biochi.2017.01.001_bib8","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2017.01.001_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ajpath.2015.10.023","article-title":"The challenge of cancer genomics in rare nervous system neoplasms: malignant peripheral nerve sheath tumors as a paradigm for cross-species comparative oncogenomics","volume":"186","author":"Carroll","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biochi.2017.01.001_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccr.2005.07.004","article-title":"Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma","volume":"8","author":"Zhu","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biochi.2017.01.001_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-8741(89)90062-7","article-title":"Medical uses of mylabris in ancient China and recent studies","volume":"26","author":"Wang","year":"1989","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.biochi.2017.01.001_bib12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/cancers7020648","article-title":"PP2A: the wolf in sheep's clothing?","volume":"7","author":"Kiely","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.biochi.2017.01.001_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1476-4598-13-157","article-title":"PP2A inhibition overcomes acquired resistance to HER2 targeted therapy","volume":"13","author":"McDermott","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biochi.2017.01.001_bib14","doi-asserted-by":"crossref","first-page":"11836","DOI":"10.1038\/srep11836","article-title":"Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA","volume":"5","author":"Shen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2017.01.001_bib15","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.3892\/or.2016.4684","article-title":"Cantharidin inhibits cell proliferation and induces apoptosis through G2\/M phase cell cycle arrest in hepatocellular carcinoma stem cells","volume":"35","author":"Le","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biochi.2017.01.001_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/01.cad.0000175586.31940.50","article-title":"In\u00a0vitro and in\u00a0vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agents","volume":"16","author":"To","year":"2005","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.biochi.2017.01.001_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/excr.1996.0340","article-title":"Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies","volume":"229","author":"Abe","year":"1996","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biochi.2017.01.001_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2165\/00003495-198530030-00002","article-title":"Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders","volume":"30","author":"Sorkin","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.biochi.2017.01.001_bib19","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.biochi.2011.07.015","article-title":"Cell proliferation, calcium influx and calcium channels","volume":"93","author":"Capiod","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.biochi.2017.01.001_bib20","first-page":"2413","article-title":"Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse","volume":"52","author":"Taylor","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.biochi.2017.01.001_bib21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.urolonc.2013.08.001","article-title":"Calcium channel blockers and prostate cancer","volume":"32","author":"Loughlin","year":"2014","journal-title":"Urol. Oncol."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908417300019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908417300019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T12:17:44Z","timestamp":1556367464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908417300019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":21,"alternative-id":["S0300908417300019"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2017.01.001","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}